Egetis Therapeutics AB (publ) (LON: 0ABW)

Egetis Therapeutics AB Revenue

Egetis Therapeutics AB had revenue of 9.40M SEK in the quarter ending September 30, 2024, a decrease of -22.95%. This brings the company's revenue in the last twelve months to 67.90M, up 121.17% year-over-year. In the year 2023, Egetis Therapeutics AB had annual revenue of 57.60M with 154.87% growth.

• Revenue (ttm): 67.90M SEK
• Revenue Growth: +121.17%
• P/S Ratio: n/a
• Revenue / Employee: 2.43M SEK
• Employees: 28
• Market Cap: 162.31M GBP

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	57.60M	35.00M	154.87%
Dec 31, 2022	22.60M	-15.60M	-40.84%
Dec 31, 2021	38.20M	-2.46M	-6.05%
Dec 31, 2020	40.66M	-41.90M	-50.75%
Dec 31, 2019	82.56M	54.35M	192.66%